BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fan XH, Geng JZ, Wang LF, Zheng YY, Lu HY, Li J, Xu XY. De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients. World J Gastroenterol 2011; 17(43): 4804-4809 [PMID: 22147982 DOI: 10.3748/wjg.v17.i43.4804]
URL: https://www.wjgnet.com/1007-9327/full/v17/i43/4804.htm
Number Citing Articles
1
M. Lee, S. Oh, H. J. Lee, T.-S. Yeum, J.-H. Lee, S. J. Yu, H. Y. Kim, J.-H. Yoon, H.-S. Lee, Y. J. Kim. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapyJournal of Viral Hepatitis 2014; 21(12): 873 doi: 10.1111/jvh.12217
2
Rong-Quan Fu. Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot studyMedical Science Monitor 2013; 19: 751 doi: 10.12659/MSM.889443
3
Ma Li-Na, Ding Xiang-Chun, Liu Xiao-Yan, Xu Chun-Qiong, Shuai-Wei Liu, Xie Yan. De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B Before PregnancyJournal of Medical Virology 2014; 86(3): 433 doi: 10.1002/jmv.23828
4
Adefovir dipivoxil/lamivudineReactions Weekly 2021; 1857(1): 17 doi: 10.1007/s40278-021-96402-z
5
Michael C. Kew. Viruses and Human Cancer2014; : 133 doi: 10.1007/978-1-4939-0870-7_7